PE20020747A1 - Taxanos de carbonato c-4 oralmente activos - Google Patents
Taxanos de carbonato c-4 oralmente activosInfo
- Publication number
- PE20020747A1 PE20020747A1 PE2001000117A PE2001000117A PE20020747A1 PE 20020747 A1 PE20020747 A1 PE 20020747A1 PE 2001000117 A PE2001000117 A PE 2001000117A PE 2001000117 A PE2001000117 A PE 2001000117A PE 20020747 A1 PE20020747 A1 PE 20020747A1
- Authority
- PE
- Peru
- Prior art keywords
- orally active
- carbonate
- taxans
- refers
- urotelial
- Prior art date
Links
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 title 1
- -1 ISOPROPYL Chemical group 0.000 abstract 3
- LFQSCWFLJHTTHZ-HQMMCQRPSA-N Ethanol-14C Chemical compound C[14CH2]O LFQSCWFLJHTTHZ-HQMMCQRPSA-N 0.000 abstract 1
- 208000017604 Hodgkin disease Diseases 0.000 abstract 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 abstract 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 abstract 1
- 208000034578 Multiple myelomas Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- FHTSIFHJYGMMMD-UHFFFAOYSA-N [C]1=CC=CO1 Chemical class [C]1=CC=CO1 FHTSIFHJYGMMMD-UHFFFAOYSA-N 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 abstract 1
- 239000008389 polyethoxylated castor oil Substances 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical class O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17996500P | 2000-02-03 | 2000-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020747A1 true PE20020747A1 (es) | 2002-08-17 |
Family
ID=22658728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000117A PE20020747A1 (es) | 2000-02-03 | 2001-02-02 | Taxanos de carbonato c-4 oralmente activos |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6750246B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1251846B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003523971A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE273005T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU778284B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2399116A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ20022956A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60012988T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1251846T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2226954T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1047891B (cg-RX-API-DMAC7.html) |
| MY (1) | MY129310A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ521136A (cg-RX-API-DMAC7.html) |
| PE (1) | PE20020747A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1251846E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2243223C2 (cg-RX-API-DMAC7.html) |
| TR (1) | TR200402454T4 (cg-RX-API-DMAC7.html) |
| TW (2) | TWI245041B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001056565A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200207037B (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| US6916942B2 (en) * | 2000-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Process for the preparation of C-4 carbonate taxanes |
| EP1623706A3 (en) * | 2001-02-28 | 2006-02-22 | Bristol-Myers Squibb Company | Metronomic dosing of taxanes for inhibiting tumor growth |
| UY27185A1 (es) * | 2001-02-28 | 2002-09-30 | Bristol Myers Squibb Co | Dosificación metronómica de taxanos |
| US7063977B2 (en) * | 2001-08-21 | 2006-06-20 | Bristol-Myers Squibb Company | Enzymatic resolution of t-butyl taxane derivatives |
| RS52904A (sr) * | 2001-12-20 | 2006-12-15 | Bristol-Myers Squib Company | Farmaceutske smeše oralno aktivnih derivata taksana koje imaju povećanu bioraspoloživost |
| US20070105944A1 (en) * | 2002-10-25 | 2007-05-10 | Comezoglu S N | Taxane metabolites |
| US7371759B2 (en) * | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| TW200533339A (en) * | 2004-03-16 | 2005-10-16 | Bristol Myers Squibb Co | Therapeutic synergy of anti-cancer compounds |
| US7459562B2 (en) * | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| TW200538453A (en) * | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
| US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7432373B2 (en) * | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| US7439246B2 (en) * | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
| US20060116420A1 (en) * | 2004-11-23 | 2006-06-01 | Ramakrishnan Chidambaram | Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel |
| US20060258736A1 (en) * | 2005-05-12 | 2006-11-16 | Bristol-Myers Squibb Company | Dosing regimen |
| US20080221135A1 (en) * | 2005-05-13 | 2008-09-11 | Bristol-Myers Squibb Company | Combination therapy |
| US7348325B2 (en) | 2005-11-30 | 2008-03-25 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| PL217731B1 (pl) | 2006-06-01 | 2014-08-29 | Tomasz Byrski | Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi |
| HRP20171537T1 (hr) | 2009-11-05 | 2017-12-15 | Rhizen Pharmaceuticals S.A. | Novi modulatori benzopiran kinaze |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY110249A (en) | 1989-05-31 | 1998-03-31 | Univ Florida State | Method for preparation of taxol using beta lactam |
| US6335362B1 (en) | 1991-09-23 | 2002-01-01 | Florida State University | Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| US6521660B2 (en) | 1991-09-23 | 2003-02-18 | Florida State University | 3′-alkyl substituted taxanes and pharmaceutical compositions containing them |
| US5399726A (en) | 1993-01-29 | 1995-03-21 | Florida State University | Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups |
| US5284865A (en) | 1991-09-23 | 1994-02-08 | Holton Robert A | Cyclohexyl substituted taxanes and pharmaceutical compositions containing them |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| RU2059631C1 (ru) * | 1991-11-29 | 1996-05-10 | Дзе Юниверсити оф Канзас | Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью |
| FR2698871B1 (fr) * | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| KR100356448B1 (ko) | 1992-12-23 | 2002-10-19 | 브리스톨-마이어스스퀴브컴파니 | 신규 측쇄-함유 탁산 및 그의 중간체 화합물 |
| US5973160A (en) | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
| US5475011A (en) * | 1993-03-26 | 1995-12-12 | The Research Foundation Of State University Of New York | Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| FR2721024B1 (fr) * | 1994-06-09 | 1996-07-12 | Rhone Poulenc Rorer Sa | Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5767296A (en) | 1994-06-09 | 1998-06-16 | Daiichi Pharmaceutical Co., Ltd. | Deacetoxytaxol derivatives |
| FR2726272B1 (fr) * | 1994-10-26 | 1996-12-06 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US5840929A (en) | 1995-04-14 | 1998-11-24 | Bristol-Myers Squibb Company | C4 methoxy ether derivatives of paclitaxel |
| TW354293B (en) | 1995-06-06 | 1999-03-11 | Bristol Myers Squibb Co | Prodrugs of paclitaxel derivatives |
| US6245805B1 (en) | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| US6964946B1 (en) | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| US5739359A (en) * | 1997-01-24 | 1998-04-14 | Virginia Tech Intellectual Properties, Inc. | Methods for preparing 1-deoxy paclitaxels |
| AU759030B2 (en) | 1997-12-31 | 2003-04-03 | Bristol-Myers Squibb Company | 2-aroyl-4-acyl paclitaxel (taxol) analogs |
| DE60007115T2 (de) | 1999-05-17 | 2004-09-02 | Bristol-Myers Squibb Co. | Neue Umsetzungsbedingungen für die Spaltung von Silylethern bei der Herstellung von Paclitaxel (Taxol) und Paclitaxelanaloga |
| ES2219372T3 (es) | 1999-08-11 | 2004-12-01 | Bristol-Myers Squibb Company | Procedimiento para preparar un analogo carbonato de metilo c-4 de paclitaxel. |
| CN1450923A (zh) | 1999-10-27 | 2003-10-22 | 巴克·诺顿药物有限公司 | 给病人口服给予紫杉烷的方法和组合物 |
| US6750246B1 (en) | 2000-02-03 | 2004-06-15 | Bristol-Myers Squibb Company | C-4 carbonate taxanes |
| JP2004520398A (ja) | 2001-01-18 | 2004-07-08 | ファルマシア・アンド・アップジョン・カンパニー | 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物 |
| UY27185A1 (es) | 2001-02-28 | 2002-09-30 | Bristol Myers Squibb Co | Dosificación metronómica de taxanos |
| DE10154464B4 (de) | 2001-11-08 | 2005-10-20 | Max Delbrueck Centrum | Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol |
| WO2003045357A1 (en) | 2001-11-27 | 2003-06-05 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
-
2000
- 2000-11-14 US US09/712,352 patent/US6750246B1/en not_active Expired - Lifetime
- 2000-11-16 WO PCT/US2000/031484 patent/WO2001056565A1/en not_active Ceased
- 2000-11-16 RU RU2002123641/04A patent/RU2243223C2/ru not_active IP Right Cessation
- 2000-11-16 AU AU17692/01A patent/AU778284B2/en not_active Ceased
- 2000-11-16 CA CA002399116A patent/CA2399116A1/en not_active Abandoned
- 2000-11-16 ES ES00980427T patent/ES2226954T3/es not_active Expired - Lifetime
- 2000-11-16 AT AT00980427T patent/ATE273005T1/de active
- 2000-11-16 CZ CZ20022956A patent/CZ20022956A3/cs unknown
- 2000-11-16 DK DK00980427T patent/DK1251846T3/da active
- 2000-11-16 DE DE60012988T patent/DE60012988T2/de not_active Expired - Lifetime
- 2000-11-16 JP JP2001556256A patent/JP2003523971A/ja active Pending
- 2000-11-16 TR TR2004/02454T patent/TR200402454T4/xx unknown
- 2000-11-16 PT PT00980427T patent/PT1251846E/pt unknown
- 2000-11-16 NZ NZ521136A patent/NZ521136A/en unknown
- 2000-11-16 HK HK03100017.6A patent/HK1047891B/en not_active IP Right Cessation
- 2000-11-16 EP EP00980427A patent/EP1251846B1/en not_active Expired - Lifetime
-
2001
- 2001-01-29 TW TW090101690A patent/TWI245041B/zh not_active IP Right Cessation
- 2001-01-29 MY MYPI20010372A patent/MY129310A/en unknown
- 2001-01-29 TW TW094114392A patent/TWI245042B/zh not_active IP Right Cessation
- 2001-02-02 PE PE2001000117A patent/PE20020747A1/es not_active Application Discontinuation
-
2002
- 2002-09-02 ZA ZA200207037A patent/ZA200207037B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20022956A3 (cs) | 2003-02-12 |
| AU1769201A (en) | 2001-08-14 |
| MY129310A (en) | 2007-03-30 |
| TR200402454T4 (tr) | 2004-12-21 |
| TWI245042B (en) | 2005-12-11 |
| PT1251846E (pt) | 2004-11-30 |
| HK1047891A1 (en) | 2003-03-14 |
| EP1251846A4 (en) | 2003-03-12 |
| JP2003523971A (ja) | 2003-08-12 |
| TW200526613A (en) | 2005-08-16 |
| AU778284B2 (en) | 2004-11-25 |
| DE60012988D1 (en) | 2004-09-16 |
| RU2002123641A (ru) | 2004-01-10 |
| EP1251846B1 (en) | 2004-08-11 |
| ES2226954T3 (es) | 2005-04-01 |
| ATE273005T1 (de) | 2004-08-15 |
| ZA200207037B (en) | 2003-12-02 |
| WO2001056565A1 (en) | 2001-08-09 |
| RU2243223C2 (ru) | 2004-12-27 |
| CA2399116A1 (en) | 2001-08-09 |
| DK1251846T3 (da) | 2004-11-29 |
| DE60012988T2 (de) | 2005-08-25 |
| TWI245041B (en) | 2005-12-11 |
| NZ521136A (en) | 2004-05-28 |
| HK1047891B (en) | 2005-01-28 |
| EP1251846A1 (en) | 2002-10-30 |
| US6750246B1 (en) | 2004-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020747A1 (es) | Taxanos de carbonato c-4 oralmente activos | |
| CY1107228T1 (el) | Αποκλειστες διαυλων νατριου | |
| NO970495L (no) | Aryltioforbindelser som anti-bakterielle og antivirale midler | |
| NO20052887L (no) | Pyridazinonderivater som GSK-3Beta inhibitorer. | |
| SE0300956L (sv) | Stabilisatorblandningar | |
| DE60215656D1 (de) | Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit | |
| NO20051066L (no) | Arylsubstituerte benzimidazoler og deres anvendelse som natriumkanalblokkere | |
| AR027117A1 (es) | Trifluorometilpirrolcarboxamidas y trifluorometilpirroltioamidas como fungicidas | |
| TW200517132A (en) | Stable aqueous antiplaque oral compositions | |
| DE60015390D1 (de) | Antidiabetische thiazolidindione und ihre herstellung | |
| MY133520A (en) | Cyclohexanediole derivatives | |
| BRPI0411664A (pt) | composição oral antiplaca aquosa estável | |
| EE04345B1 (et) | Simvastatiini ja selle derivaatide valmistamise protsess | |
| ZA935619B (en) | Cyanoguanidines as k-channel blockers | |
| TW200504201A (en) | Liquid detergent composition | |
| NO983531L (no) | Dihydrobenzofuranforbindelser anvendelig som anti-inflammatoriske midler | |
| MY125378A (en) | Pentacyclic taxan compound | |
| EA200201023A1 (ru) | Ингибитор натрий-водородного обмена типа 1(nhe-1) | |
| AR038380A1 (es) | 2 ' -halo-3 ' , 5 ' -dialcoxi-fen-1' -il-imino-2-imidazolidinas y su uso como un farmaco | |
| ES2182523T3 (es) | Derivados de indolilo como agentes serotonergicos. | |
| ID22762A (id) | Komposisi untuk mengobati atau mencegah kanker prostat | |
| ES2186324T3 (es) | Nuevos macroliquidos citotoxicos conteniendo tris (oxazol). | |
| EA200200416A1 (ru) | Кристаллы ингибитора натрий-водородного обмена 1 типа | |
| DK1417265T3 (da) | Flydende farvesammensætninger med acyglyceroler som dispergeringsmidler | |
| ES2189506T3 (es) | Sintesis de aluminoxanos que emplea una cantidad reducida de compuesto de trialquilaluminio. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |